Prospective Study of Patients Treated with Palliative Radiation Therapy While on Immunotherapy.

ABSTRACT:

Purpose

To prospectively document the outcomes of patients treated with palliative radiation therapy (RT) who are receiving immunotherapy.

Methods and materials

Patients with advanced cancer receiving or planning to commence immunotherapy within 28 days who were referred for palliative RT at our center between January 2017 and September 2019 were screened for participation in this prospective observational study. Demographic and treatment data, along with patient-reported outcomes (PROs) using the Edmonton Symptom Assessment Scale for cancer, were collected at baseline, after 1 month, and then every 3 months for up to 1 year or until death. RT dose and fractionation were at the discretion of the treating radiation oncologist. Immunotherapy was given as per the standard of ca

SUBMITTER: Harris G 

PROVIDER: S-EPMC11982977 | biostudies-literature | 2025 Apr

REPOSITORIES: biostudies-literature